Scientific Programme
Scientific Programme
Search Abstract
Session

Poster session: Molecular targeting / Gene Therapy
Date: Friday, 7 June 2002
Time: 17:15-18:45
Room: 


17:15-18:45 0449
mRNA electroporation of human monocytes followed by rapid in vitro differentiation leads to highly stimulatory mature antigen-loaded dendritic cells
P. Ponsaerts, G. Van den Bosch, N. Cools, A. Van Driessche, G. Nijs, M. Lenjou, D.R. Van Bockstaele, Z.N. Berneman, V.F.I. Van Tendeloo (Edegem (antwerp), Belgium)

17:15-18:45 0450
mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation
P. Ponsaerts, V.F.I. van Tendeloo, N. Cools, A. Van Driessche, F. Lardon, G. Nijs, M. Lenjou, G. Mertens, C. van Broeckhoven, D.R. van Bockstaele, Z.N. Berneman (Edegem (antwerp), Belgium)

17:15-18:45 0451
THE USE OF ATRA AND TRAIL IN COMBINATION FOR THE TREATMENT OF ACUTE MYELOID LEUKAEMIA
A. Awan, K. Tobal, J. Adams, J. A. Liu Yin (Manchester, United Kingdom)

17:15-18:45 0452
TARGETING SURVIVIN WITH DNAZYMES EFFICIENTLY CLEAVES ITS TRANSCRIPTS AND INDUCES APOPTOSIS IN MYELOID LEUKAEMIAS
K. Tobal, M. Kabuli, R. Brooke, J.A. Liu Yin, J.A. Liu Yin (Manchester, United Kingdom)

17:15-18:45 0453
DNAZYMES TARGETING THE XIAP CLEAVE ITS TRANSCRIPT AND INDUCES APOPTOSIS IN MYELOID LEUKAEMIAS
K. Tobal, M. Kabuli, R. Brooke, J.A. Liu Yin (Manchester, United Kingdom)

17:15-18:45 0454
Inhibition of ETO mediated repression of gene expression by interfering peptides
S. Schüle, D. Hildebrand, M. Grez (Frankfurt/ Main, Germany)

17:15-18:45 0455
ANTISENSE DOWNREGULATION OF GENE EXPRESSION IN CHRONIC MYELOID LEUKEMIA; DELIVERY COUNTS
M. Lawler, L. O Connor, S. McElwaine, K. Gately, D. Hollywood, T. Cotter, S.R. McCann, M. Lawler (Dublin, Ireland)

17:15-18:45 0456
Chemoprotection of marrow-repopulating human peripheral blood progenitor cells transduced with the human multidrug resistance-1 gene
S. Fruehauf, B. Schiedlmeier, A.L. Schilz, S. Naundorf, K. Kühlcke, C. Baum, W.J. Zeller, H.G. Eckert, S. Laufs (Heidelberg, Germany)

17:15-18:45 0457
DEVELOPMENT OF AN IMPROVED PROTOCOL TO TRANSDUCE B CELL PRECURSOR ALL BLASTS WITH LENTIVIRAL VECTORS DRIVING HIGH EXPRESSION OF A TRANSGENE
M. Introna, M. Bonamino, E. Biagi, G. Gaipa, E. Todisco, J. Golay, A. Biondi (Milano, Italy)

17:15-18:45 0458
PML/RAR `alpha'-TARGETING DNAZYMES SUPRESS PROLIFERATION AND INDUCE APOPTOSIS IN APL CELLS
A. Kabuli, R. Brooke, K. Tobal, J.A. Liu Yin (Manchester, United Kingdom)

17:15-18:45 0459
TARGETING OF THE OLIGOMERIZATION INTERFACE OF ABL-FUSION PROTEINS INFLUENCES SENSITIVITY TO STI571
T. Beissert, D. Hoelzer, O.G. Ottmann, M. and Ruthardt (Frankfurt, Germany)

17:15-18:45 0460
Adenovirally Transduced Dendritic Cells Induce Bispecific CTL Responses against both Adenovirus and CMVpp65 or EBV EBNA3C Protein: A Novel Approach for Immunotherapy
Y.H. Hamel, N.W.B. Blake, S.G. Gabrielsson, T.H. Haigh, K.J. Joos, A.B.R. Rickinson, A.F. Fischer, M.C.C. Cavazzana-Calvo (Paris, France)

17:15-18:45 0461
Correction of the Immunodeficiency and Lack of Toxicity after Retroviral-Mediated RAG-2 Gene Transfer in RAG-2 Deficient Mice
F. Yates, M Malassis-Séris, D.B. Kohn, O. Danos, A. Fischer, J.P. de Villartay, M. Cavazzana-Calvo (Paris, France)

17:15-18:45 0462
ADENYLOSUCCINAT-SYNTHEASE AND ADENOSINE KINASE INHIBITION AS THERAPEUTIC TARGETS IN MTAP-NEGATIVE MALIGNANCIES
M.S. Schmid, H. Ruff, K. Lehmann, H. Cottam, H. Doehner (Ulm, Germany)

17:15-18:45 0463
DOWN MODULATION OF SHP2 TYROSINE PHOSPHATASE AS EARLY EVENT OF IN VITRO RESISTANCE TO STI571
C. Quintarelli, R. Di Noto, G. Muccioli Casadei, A. Sparacino, M. Bartiromo, B. Izzo, M. Intrieri, D. Alberti, G. Rosti, M. Baccarani, G. Saglio, F. Pane, F. Salvatore (Napoli, Italy)